[1] Chung BH, et al. Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase. Exp Mol Med. 2012 Mar 31;44(3):191-201. DOI:
10.3858/emm.2012.44.3.014[2] Wang X, et al. Syringaresinol attenuates osteoarthritis via regulating the NF-κB pathway. Int Immunopharmacol. 2023 May;118:109982. DOI:
10.1016/j.intimp.2023.109982[3] Y C Wu, et al. Bioactive constitutents from the stems of Annona Montana. Planta Med. 1995 Apr;61(2):146-9. DOI:
10.1055/s-2006-958035